Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Journal of Thrombosis and Haemostasis : JTH
|
March 28, 2021
CLEC-2 stimulates IGF-1 secretion from podoplanin-positive stromal cells and positively regulates erythropoiesis in mice
Shimon Otake, Tomoyuki Sasaki, Toshiaki Shirai, et al.
Medicine
|
November 13, 2024
Successful treatment for a patient with antiphospholipid syndrome and decreased protein S activity exacerbated by heparin-induced thrombocytopenia: A case report
Masahiro Nishihara, Hiroto Nagae, Shimon Otake, et al.
Journal of Clinical and Experimental Hematopathology : JCEH
|
June 29, 2025
Brentuximab vedotin monotherapy for CD30-positive adult T-cell leukemia/lymphoma with HTLV-1-infected Hodgkin and Reed-Sternberg-like cells
Shun Ito, Hiromichi Takahashi, Haruna Watanabe-Nishimaki, et al.
Journal of Clinical and Experimental Hematopathology : JCEH
|
June 1, 2025
The outcome of patients with peripheral T cell lymphoma treated with doxorubicin-based (CHOP) and pirarubicin-based regimen (THP-COP) regimen: a single institution experience
Noriyoshi Iriyama, Katsuhiro Miura, Hiromichi Takahashi, et al.
Research and Practice in Thrombosis and Haemostasis
|
June 9, 2025
C-type lectin-like receptor 2 in platelets amplifies inflammation in rheumatoid arthritis
Tomoyuki Sasaki, Ewelina Golebiewska, Toshiaki Shirai, et al.
Hematology Reports
|
November 24, 2025
Role of Daratumumab, Lenalidomide, and Dexamethasone in Transplantation-Eligible Patients with Multiple Myeloma After the Failure of Bortezomib-Based Induction Therapy
Shun Ito, Takashi Hamada, Masaru Nakagawa, et al.
Blood Advances
|
April 12, 2021
Heme activates platelets and exacerbates rhabdomyolysis-induced acute kidney injury via CLEC-2 and GPVI/FcRγ
Saori Oishi, Nagaharu Tsukiji, Shimon Otake, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
March 4, 2026
[Venetoclax plus azacitidine as successful bridging therapy to second transplantation for post-transplant extramedullary relapse of acute myeloid leukemia]
Toshihide Endo, Hiromichi Takahashi, Takahiro Namiki, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
May 11, 2018
[Achievement of a stringent complete response with low-dose pomalidomide monotherapy in a multiple myeloma patient]
Toshihide Endo, Takashi Hamada, Shimon Otake, et al.
International Journal of Hematology
|
April 26, 2026
Rapid regression of a bulky cranial lesion in high-risk multiple myeloma with isatuximab-based quadruplet induction
Shun Ito, Takahiro Namiki, Hironao Nukariya, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Journal of Thrombosis and Haemostasis : JTH
|
March 28, 2021
CLEC-2 stimulates IGF-1 secretion from podoplanin-positive stromal cells and positively regulates erythropoiesis in mice
Shimon Otake, Tomoyuki Sasaki, Toshiaki Shirai, et al.
Medicine
|
November 13, 2024
Successful treatment for a patient with antiphospholipid syndrome and decreased protein S activity exacerbated by heparin-induced thrombocytopenia: A case report
Masahiro Nishihara, Hiroto Nagae, Shimon Otake, et al.
Journal of Clinical and Experimental Hematopathology : JCEH
|
June 29, 2025
Brentuximab vedotin monotherapy for CD30-positive adult T-cell leukemia/lymphoma with HTLV-1-infected Hodgkin and Reed-Sternberg-like cells
Shun Ito, Hiromichi Takahashi, Haruna Watanabe-Nishimaki, et al.
Journal of Clinical and Experimental Hematopathology : JCEH
|
June 1, 2025
The outcome of patients with peripheral T cell lymphoma treated with doxorubicin-based (CHOP) and pirarubicin-based regimen (THP-COP) regimen: a single institution experience
Noriyoshi Iriyama, Katsuhiro Miura, Hiromichi Takahashi, et al.
Research and Practice in Thrombosis and Haemostasis
|
June 9, 2025
C-type lectin-like receptor 2 in platelets amplifies inflammation in rheumatoid arthritis
Tomoyuki Sasaki, Ewelina Golebiewska, Toshiaki Shirai, et al.
Hematology Reports
|
November 24, 2025
Role of Daratumumab, Lenalidomide, and Dexamethasone in Transplantation-Eligible Patients with Multiple Myeloma After the Failure of Bortezomib-Based Induction Therapy
Shun Ito, Takashi Hamada, Masaru Nakagawa, et al.
Blood Advances
|
April 12, 2021
Heme activates platelets and exacerbates rhabdomyolysis-induced acute kidney injury via CLEC-2 and GPVI/FcRγ
Saori Oishi, Nagaharu Tsukiji, Shimon Otake, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
March 4, 2026
[Venetoclax plus azacitidine as successful bridging therapy to second transplantation for post-transplant extramedullary relapse of acute myeloid leukemia]
Toshihide Endo, Hiromichi Takahashi, Takahiro Namiki, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
May 11, 2018
[Achievement of a stringent complete response with low-dose pomalidomide monotherapy in a multiple myeloma patient]
Toshihide Endo, Takashi Hamada, Shimon Otake, et al.
International Journal of Hematology
|
April 26, 2026
Rapid regression of a bulky cranial lesion in high-risk multiple myeloma with isatuximab-based quadruplet induction
Shun Ito, Takahiro Namiki, Hironao Nukariya, et al.
Page
of 2